Humana Inc vs iShares 3 7 Year Treasury Bond ETF — how do they compare? Humana Inc trades at $374.25 (market cap $46.31B), while iShares 3 7 Year Treasury Bond ETF trades at $116.36. The key difference: Humana Inc pays a 0.92% dividend while iShares 3 7 Year Treasury Bond ETF pays none, and Humana Inc is trading nearer its 52-week high, iShares 3 7 Year Treasury Bond ETF nearer its low. Which is the better fit depends on your goals.
| HUM | IEI | |
|---|---|---|
Market Cap | $46.31B | — |
Sector | Health | Fixed Income |
52-Week High | $409.42 | $120.72 |
52-Week Low | $163.67 | $116.16 |
Enterprise Value | $53.67B | — |
Dividend Yield | 0.92% | — |
Signals from Pluang's Aura AI — not financial advice
Humana (HUM) trades at $385.00, up 4.82% today, with a bullish technical outlook and analyst consensus price target of $399.53. Recent earnings beats in Q1 and Q2 2026, alongside revenue growth to $129.66 billion in 2025, support fundamentals, though net margins have compressed. The company is expanding its Medicaid business and targeting margin improvements by 2027.
The stock offers upside to consensus targets but faces risks from Medicare Advantage margin pressures and regulatory changes. Profitability trends are weak despite revenue growth, requiring successful cost management to meet 2028 targets. Institutional sentiment is mixed with a majority hold rating.
IEI trades at $116.55, up 0.19% on the day, with a neutral technical signal and bearish moving averages. The ETF shows consistent dividend payouts, with recent distributions of $0.37-$0.38. Treasury yield volatility, driven by inflation data and geopolitical tensions, influences price action, while institutional interest is mixed, with Bank of America increasing its stake as of August 2026.
Outlook remains tied to Federal Reserve policy and inflation trends, offering stability but limited growth. Risks include rising yields pressuring bond prices and Middle East instability affecting oil markets. Income-focused investors may find value in its government-backed yield amid ongoing market uncertainty.
Trailing returns across standard periods
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →IEI tracks the ICE U.S. Treasury 3-7 Year Bond Index, offering exposure to intermediate-term government debt. It serves as a conservative middle ground in the Treasury yield curve, providing higher yields than short-term bills with less volatility than long-term bonds.
Read more on IEI →